相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prolonged and symptomatic bradycardia following a single dose of fingolimod
Hans Faber et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Vitamin D and multiple sclerosis. The role for risk of disease and treatment
A. Doering et al.
NERVENARZT (2013)
Higher macular volume in patients with MS receiving fingolimod Positive outcome or side effect?
Marc Dinkin et al.
NEUROLOGY (2013)
Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets
Junpeng Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Neutrophil Protease Inhibition Reduces Neuromyelitis Optica-Immunoglobulin G-Induced Damage in Mouse Brain
Samira Saadoun et al.
ANNALS OF NEUROLOGY (2012)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Multiple Sclerosis Lesions and Irreversible Brain Tissue Damage A Comparative Ultrahigh-Field Strength Magnetic Resonance Imaging Study
Tim Sinnecker et al.
ARCHIVES OF NEUROLOGY (2012)
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Ingo Kleiter et al.
ARCHIVES OF NEUROLOGY (2012)
P02.26. Integrative care for adolescent mood problems: brief report from a second opinion clinic
K Kemper et al.
BMC Complementary and Alternative Medicine (2012)
EGCG Ameliorates the Suppression of Long-Term Potentiation Induced by Ischemia at the Schaffer Collateral-CA1 Synapse in the Rat
Jie Ding et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Amyotrophic lateral sclerosis
Albert C. Ludolph et al.
CURRENT OPINION IN NEUROLOGY (2012)
Conventional brain MRI in neuromyelitis optica
J. A. Cabrera-Gomez et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea
Yoshiko Nakae et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2012)
Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo-controlled, crossover investigation
Emma L. Wightman et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
Pharmacokinetics and Blood-Brain Barrier Penetration of (+)-Catechin and (-)-Epicatechin in Rats by Microdialysis Sampling Coupled to High-Performance Liquid Chromatography with Chemiluminescence Detection
Liang Wu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Dual Role of Selected Antioxidants Found in Dietary Supplements: Crossover between Anti- and Pro-Oxidant Activities in the Presence of Copper
Jun-Jie Yin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Green Tea Polyphenols Precondition against Cell Death Induced by Oxygen-Glucose Deprivation via Stimulation of Laminin Receptor, Generation of Reactive Oxygen Species, and Activation of Protein Kinase Cε
Usha Gundimeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Dynamics of saccade parameters in multiple sclerosis patients with fatigue
Carsten Finke et al.
JOURNAL OF NEUROLOGY (2012)
Does fingolimod in multiple sclerosis patients cause macular edema?
Kiran Turaka et al.
JOURNAL OF NEUROLOGY (2012)
Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice
Munkyong Pae et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?
Christian Veauthier et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis
M. B. D'hooghe et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy
M. H. Barnett et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
Ju-Hong Min et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Sudden unexpected death on fingolimod
J. W. Lindsey et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Vitamin D and multiple sclerosis: an interaction between genes and environment
Adam E. Handel et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence
G. Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Su-Hyun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success
Benjamin M. Greenberg et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein
Katja Herges et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
Per Soelberg Sorensen et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Impact of epigallo catechin-3-gallate on acetylcholine-acetylcholine esterase cycle in aged rat brain
Ravichandran Srividhya et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
The ALS-FTD-Q A new screening tool for behavioral disturbances in ALS
Joost Raaphorst et al.
NEUROLOGY (2012)
No MRI evidence of cortical lesions in neuromyelitis optica
Massimiliano Calabrese et al.
NEUROLOGY (2012)
Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62 A functional convergence?
Stanley H. Appel et al.
NEUROLOGY (2012)
Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS
Colin Quinn et al.
NEUROLOGY (2012)
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Elisa Rubino et al.
NEUROLOGY (2012)
DOES NATALIZUMAB THERAPY WORSEN NEUROMYELITIS OPTICA?
Anu Jacob et al.
NEUROLOGY (2012)
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
Tim Sinnecker et al.
NEUROLOGY (2012)
Fingolimod-associated macular edema Incidence, detection, and management
Nieraj Jain et al.
NEUROLOGY (2012)
Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology
Justin Y. Kwan et al.
PLOS ONE (2012)
Adult Neurogenesis Transiently Generates Oxidative Stress
Noah M. Walton et al.
PLOS ONE (2012)
Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology
Letizia Granieri et al.
PLOS ONE (2012)
Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis
Coralie Chanvillard et al.
PLOS ONE (2012)
Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis
Johannes Brettschneider et al.
PLOS ONE (2012)
The Cortical Signature of Amyotrophic Lateral Sclerosis
Federica Agosta et al.
PLOS ONE (2012)
Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum
Patricia Lillo et al.
PLOS ONE (2012)
A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease
Mibel M. Pabon et al.
PLOS ONE (2012)
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
Anke Stroet et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Exercise in multiple sclerosis - an integral component of disease management
Andrea Doering et al.
EPMA JOURNAL (2012)
Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy
Nadja Borisow et al.
EPMA JOURNAL (2012)
General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
Olga Golubnitschaja et al.
EPMA JOURNAL (2012)
Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
Su-Hyun Kim et al.
ARCHIVES OF NEUROLOGY (2011)
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography
A. U. Brandt et al.
BRAIN (2011)
Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome
Anand Kamal Sachdeva et al.
BRAIN RESEARCH BULLETIN (2011)
Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
Derliz Mereles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
Lalida Rojanathammanee et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Progressive multifocal leukoencephalopathy and natalizumab
Kerstin Hellwig et al.
JOURNAL OF NEUROLOGY (2011)
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Delayed fingolimod-associated asystole
Patricio S. Espinosa et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Prevention and treatment of MS: studying the effects of vitamin D
Kassandra L. Munger et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study
E. Le Page et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Critical appraisal of animal models of multiple sclerosis
David Baker et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study
C. Veauthier et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials
David Bates
NEUROLOGY (2011)
Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis
C. Otto et al.
NEUROLOGY (2011)
Small-fiber neuropathy in patients with ALS
J. Weis et al.
NEUROLOGY (2011)
Functional changes in Duchenne muscular dystrophy A 12-month longitudinal cohort study
E. Mazzone et al.
NEUROLOGY (2011)
Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
C. Costanzi et al.
NEUROLOGY (2011)
Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy
M. -A. Weber et al.
NEUROLOGY (2011)
Sun exposure and vitamin D are independent risk factors for CNS demyelination
R. M. Lucas et al.
NEUROLOGY (2011)
(-)-Epigallocatechin-3-gallate Protects Against Neuronal Cell Death and Improves Cerebral Function After Traumatic Brain Injury in Rats
Tatsuki Itoh et al.
NEUROMOLECULAR MEDICINE (2011)
The Epidemiology of Multiple Sclerosis in Scotland: Inferences from Hospital Admissions
Adam E. Handel et al.
PLOS ONE (2011)
Smoking and Multiple Sclerosis: An Updated Meta-Analysis
Adam E. Handel et al.
PLOS ONE (2011)
Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy
Tamara Castillo-Trivino et al.
PLOS ONE (2011)
Functional Characterization of Aquaporin-4 Specific T Cells: Towards a Model for Neuromyelitis Optica
Sudhakar Reddy Kalluri et al.
PLOS ONE (2011)
Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis
Caspar F. Pfueller et al.
PLOS ONE (2011)
Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis
Jan Doerr et al.
PLOS ONE (2011)
Comparative Brain Stem Lesions on MRI of Acute Disseminated Encephalomyelitis, Neuromyelitis Optica, and Multiple Sclerosis
Zhengqi Lu et al.
PLOS ONE (2011)
Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegans
Yiyuan Yuan et al.
PLOS ONE (2011)
The Use of Serum Glial Fibrillary Acidic Protein Measurements in the Diagnosis of Neuromyelitis Optica Spectrum Optic Neuritis
Mithu Storoni et al.
PLOS ONE (2011)
Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
Katja Herges et al.
PLOS ONE (2011)
Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema
Julien Ratelade et al.
PLOS ONE (2011)
The chemistry and biotransformation of tea constituents
Shengmin Sang et al.
PHARMACOLOGICAL RESEARCH (2011)
Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
Jacqueline Palace et al.
ARCHIVES OF NEUROLOGY (2010)
Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro
Guang-Xun Li et al.
CARCINOGENESIS (2010)
Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects
Maria Eugenia Letelier et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients
Markus Bock et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Green tea extract decreases muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx mice
Nicholas P. Evans et al.
CLINICAL NUTRITION (2010)
The natural history of Caenorhabditis elegans
Marie-Anne Felix et al.
CURRENT BIOLOGY (2010)
Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study
F. Thielecke et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2010)
Epigallocatechin-3-gallate protects motor neurons and regulates glutamate level
Jixu Yu et al.
FEBS LETTERS (2010)
Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Ji Seon Kim et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management
Rex D. Simmons et al.
JOURNAL OF NEUROLOGY (2010)
Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia
Jong-Wook Park et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Metals, oxidative stress and neurodegenerative disorders
Klaudia Jomova et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
Attention Network Test reveals alerting network dysfunction in multiple sclerosis
Carsten Urbanek et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Correlation of self-assessed fatigue and alertness in multiple sclerosis
Nicholetta Weinges-Evers et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study
Markus Bock et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Improving the translational hit of experimental treatments in multiple sclerosis
Hanna M. Vesterinen et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The mechanism of action of glatiramer acetate treatment in multiple sclerosis
Michael K. Racke et al.
NEUROLOGY (2010)
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
J. Shimizu et al.
NEUROLOGY (2010)
Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains
Shyh-Mirn Lin et al.
NUTRITION (2010)
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Chiara Zuccato et al.
PHYSIOLOGICAL REVIEWS (2010)
Motor Neuron Synapse and Axon Defects in a C. elegans Alpha-Tubulin Mutant
Renee Baran et al.
PLOS ONE (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
Simone Mader et al.
PLOS ONE (2010)
Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
Ki Sung Kang et al.
PLOS ONE (2010)
Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica
Patricia A. Nelson et al.
PLOS ONE (2010)
Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants
Cintia Roodveldt et al.
PLOS ONE (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lower Motor Neuron Loss in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Johannes Vogt et al.
ANNALS OF NEUROLOGY (2009)
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2009)
Neuroprotective effect of epigallocatechin-3-gallate against β-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity
Chang-Yul Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (-)-epigallocatechin gallate
Olivier M. Dorchies et al.
BIOFACTORS (2009)
Neuroprotective Effects of (-)-Epigallocatechin-3-gallate on Aging Mice Induced by D-Galactose
Miao He et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection
Katherine R. Leaver et al.
BRAIN RESEARCH BULLETIN (2009)
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Bayani Uttara et al.
CURRENT NEUROPHARMACOLOGY (2009)
Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism
Puneet Kumar et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling
Dayong Wu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress
Longze Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Green Tea Polyphenol (-)-Epigallocatechin Gallate Reduces Neuronal Cell Damage and Up-Regulation of MMP-9 Activity in Hippocampal CA1 and CA2 Areas Following Transient Global Cerebral Ischemia
Jong-Wan Park et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice
Jae Woong Lee et al.
JOURNAL OF NUTRITION (2009)
Fatigued patients with multiple sclerosis have impaired central muscle activation
A. K. Andreasen et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT
J. Doerr et al.
NEUROLOGY (2009)
Epigallocatechin Gallate from Green Tea (Camellia sinensis) Increases Lifespan and Stress Resistance in Caenorhabditis elegans
Sami Abbas et al.
PLANTA MEDICA (2009)
Neuroendocrine Disturbances in Huntington's Disease
Nadine Saleh et al.
PLOS ONE (2009)
The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis
Douglas S. Goodin
PLOS ONE (2009)
Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2009)
Smoking and tea consumption delay onset of Parkinson's disease
Boris Kandinov et al.
PARKINSONISM & RELATED DISORDERS (2009)
Green and Black Tea Consumption and Risk of Stroke A Meta-Analysis
Lenore Arab et al.
STROKE (2009)
Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2008)
Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis
Patricia A. Abboud et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast
Qingying Meng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice:: a quantitative histological, immunohistochemical and electrophysiological study
Yoshiko Nakae et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate
Ravichandran Srividhya et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2008)
Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract
Jarrod A. Call et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Animal models of multiple sclerosis for the development and validation of novel therapies - potential and limitations
Eilhard Mix et al.
JOURNAL OF NEUROLOGY (2008)
Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
H. Wiendl et al.
JOURNAL OF NEUROLOGY (2008)
Smoking worsens the prognosis in multiple sclerosis
P. Sundstrom et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (-)-epigallocatechin-3-O-gallate
B. T. Zhu et al.
XENOBIOTICA (2008)
Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study
Louis C. Tan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis
Yuko Shimizu et al.
JOURNAL OF NEUROLOGY (2008)
Coffee and tea consumption and the risk of Parkinson's disease
Gang Hu et al.
MOVEMENT DISORDERS (2007)
(-)-epigallocatechin gallate, the most active polyphenolic catechin in green tea, presynaptically facilitates Ca2+-Dependent glutamate release via activation of protein kinase C in rat cerebral cortex
Chien-Wen Chou et al.
SYNAPSE (2007)
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
E. Gordon-Lipkin et al.
NEUROLOGY (2007)
Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors
D. A. Trojan et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
Cindy Voisine et al.
PLOS ONE (2007)
Smoking is a risk factor for multiple sclerosis: a metanalysis
C. H. Hawkes
MULTIPLE SCLEROSIS JOURNAL (2007)
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Ranjan Dutta et al.
NEUROLOGY (2007)
Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica
Friedemann Paul et al.
PLOS MEDICINE (2007)
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
C. Papeix et al.
MULTIPLE SCLEROSIS (2007)
Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
F. Paul et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Free radicals and antioxidants in normal physiological functions and human disease
Marian Valko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Beneficial effects of natural antioxidants EGCG and α-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans
Marishka K. Brown et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis
Zhihao Xu et al.
NEUROCHEMICAL RESEARCH (2006)
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Dagmar E. Ehrnhoefer et al.
HUMAN MOLECULAR GENETICS (2006)
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis
Lawrence Steinman et al.
ANNALS OF NEUROLOGY (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration
Brad A. Sutherland et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2006)
Reduction of iron-regulated amyloid precursor protein and β-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures:: implications for iron chelation in Alzheimer's disease
L Reznichenko et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice
SH Koh et al.
NEUROSCIENCE LETTERS (2006)
Do flavan-3-ols from green tea reach the human brain?
Andrea Zini et al.
NUTRITIONAL NEUROSCIENCE (2006)
Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy
OM Dorchies et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders
Mark F. McCarty
MEDICAL HYPOTHESES (2006)
Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues
JD Lambert et al.
DRUG METABOLISM AND DISPOSITION (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone
S Goffette et al.
JOURNAL OF NEUROLOGY (2005)
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
K Rezai-Zadeh et al.
JOURNAL OF NEUROSCIENCE (2005)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
(-)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia
RMA Rahman et al.
NEUROSCIENCE LETTERS (2005)
Green tea polyphenol (-)-epigallocatechin gallate attenuates the neuronal NADPH-d/nNOS expression in the nodose ganglion of acute hypoxic rats
IH Wei et al.
BRAIN RESEARCH (2004)
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue
JS Henkel et al.
ANNALS OF NEUROLOGY (2004)
β-Secretase inhibition for the treatment of Alzheimer's disease -: promise and challenge
M Citron
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils
H Lee et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats
YB Choi et al.
BRAIN RESEARCH (2004)
(-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury
R Li et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Iron, brain ageing and neurodegenerative disorders
L Zecca et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis
O Aktas et al.
JOURNAL OF IMMUNOLOGY (2004)
A combination of tea (Camellia senensis) catechins is required for optimal inhibition of induced CYP1A expression by green tea extract
SN Williams et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2003)
Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils
SY Lee et al.
BRAIN RESEARCH BULLETIN (2003)
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS
PG Ince et al.
NEUROLOGY (2003)
A single ascending dose study of epigallocatechin gallate in healthy volunteers
U Ullmann et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2003)
Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury
TH Pan et al.
LIFE SCIENCES (2003)
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
DB Drachman et al.
ANNALS OF NEUROLOGY (2002)
(-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant
K Nagai et al.
BRAIN RESEARCH (2002)
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate
JY Choi et al.
NEUROTOXICOLOGY (2002)
Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake
H Checkoway et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappa B) activation and cell death by tea extracts in neuronal cultures
Y Levites et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells
GJ Nie et al.
REDOX REPORT (2002)
The green tea polyphenol (-)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons
YT Choi et al.
LIFE SCIENCES (2001)
Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS
CM Ellis et al.
NEUROLOGY (2001)
Immune reactivity in a mouse model of familial ALS correlates with disease progression
ME Alexianu et al.
NEUROLOGY (2001)
Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration
Y Levites et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Spin-trapping study on the hydroxyl radical formed from a tea catechin-Cu(II) system
H Yoshioka et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2001)
Medical progress: Amyotrophic lateral sclerosis.
LP Rowland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury
JT Hong et al.
BRAIN RESEARCH BULLETIN (2000)
Extramotor involvement in ALS:: PET studies with the GABAA ligand [11C]flumazenil
CM Lloyd et al.
BRAIN (2000)
Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils
SR Lee et al.
NEUROSCIENCE LETTERS (2000)
Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols
SB Kim et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2000)
分享论文
